Dantrolene for the treatment of MDMA toxicity

Canadian Journal of Emergency Medicine

Volumn 12, Issue 5, 2010, Pages 457-459

  Grunau, Brian E ^a   Wiens, Matthew O ^a,b   Greidanus, Marc ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Chilliwack General Hospital   (Canada)

Author keywords

Dantrolene; MDMA; MDMA related hyperpyrexia; Toxicology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CREATINE KINASE; DANTROLENE; LITHIUM; LORAZEPAM; VALPROIC ACID; CENTRAL MUSCLE RELAXANT;

ADULT; AGITATION; ARTICLE; ARTIFICIAL VENTILATION; AXILLA TEMPERATURE; BLOOD PRESSURE; BREATHING RATE; CASE REPORT; CONSCIOUSNESS DISORDER; CONVALESCENCE; COOLING; CREATINE KINASE BLOOD LEVEL; DIAPHORESIS; DISEASE COURSE; DISORIENTATION; DRUG DEPENDENCE; EMERGENCY WARD; FLUSHING; FOLLOW UP; GLASGOW COMA SCALE; HEART RATE; HUMAN; HYPERPYREXIA; LEUKOCYTOSIS; LITHIUM BLOOD LEVEL; MALE; MENTAL HEALTH; MENTAL PERFORMANCE; MUSCLE RIGIDITY; MYDRIASIS; ORIENTATION; OXYGEN SATURATION; PHYSICAL EXAMINATION; PSYCHOSIS; RECTUM TEMPERATURE; RESTLESSNESS; RHABDOMYOLYSIS; ROOM TEMPERATURE; SEDATION; SHIVERING; TACHYPNEA; TREMOR; URINALYSIS; URINE VOLUME;

ADULT; DANTROLENE; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE;

EID: 79952196979     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/S1481803500012653     Document Type: Article

References (11)

1. Merck E, inventor. Varfeharen Zur Darstellung Von Alkyloxyaryl- Dialyoxyaryl-Und Alkylenedioxyarylaminopropanen Bzw. Deren Am Stickstoff Monoalkylierten. German patent 274350. 1914.
2. Adlaf EM, Begin P, Sawka E. Canadian Addiction Survey (CAS): a national survey of Canadians' use of alcohol and other drugs: prevalence of use and related harms, detailed report. Ottawa (ON): Canadian Centre on Substance Abuse (CCSA); 2005.
3. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance - United States, 2007. MMWR Surveill Summ 2008;57:1-131.
4. Gore SM. Fatal uncertainty: death-rate from use of ecstasy or heroin. Lancet 1999;354:1265-6. (Pubitemid 29469362)
5. Hall AP, Henry JA. Acute toxic effects of "ecstacy" (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006;96:678-85.
6. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20.
7. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 2001;165:917-28.
8. Larner AJ. Dantrolene and "ecstasy" overdose. Anaesthesia 1993;48:179-80.
9. Singarajah C, Lavies NG. An overdose of ecstasy. A role for dantrolene. Anaesthesia 1992;47:686-7.
10. Duffy MR, Ferguson C. Role of dantrolene in treatment of heat stroke associated with ecstasy ingestion. Br J Anaesth 2007;98:148-9. (Pubitemid 44896771)
11. Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM 2010;12:435-42.